Literature DB >> 22162247

Indications for radiotherapy after neck dissection.

Primož Strojan1, Alfio Ferlito, Johannes A Langendijk, Carl E Silver.   

Abstract

Up-front surgery and postoperative radiotherapy constitute a well-recognized treatment concept for locally or regionally advanced squamous cell carcinoma of the head and neck. This "treatment package" is further intensified with the concomitant application of chemotherapy during irradiation when high-risk features (ie, microscopically involved resection margins, extracapsular extension of the tumor from neck nodes, the presence of soft tissue deposits) are found on histopathologic examination of a resected specimen. With regard to neck disease, however, the demarcation line between low- and higher-risk clinical situations, which would differ with respect to the need for postoperative radiotherapy, is not clear. In an attempt to define the low-risk characteristics of disease in the neck that do not require adjuvant irradiation, we reviewed the available literature reports for any direct or indirect evidence on the value of postoperative radiotherapy in various clinical scenarios. The number of positive lymph nodes found in a dissected tissue specimen that should be used as a "cut-off" point for introduction of postoperative radiotherapy was evaluated in the context of both primary tumor characteristics and type of neck dissection.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 22162247     DOI: 10.1002/hed.21599

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  When is radiation therapy in head and neck squamous cell carcinoma not indicated?

Authors:  William M Mendenhall; Primož Strojan; Carl E Silver; Randall P Owen; Alessandra Rinaldo; Ashok R Shaha; Avraham Eisbruch; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-20       Impact factor: 2.503

Review 2.  The evolving role of selective neck dissection for head and neck squamous cell carcinoma.

Authors:  K Thomas Robbins; Alfio Ferlito; Jatin P Shah; Marc Hamoir; Robert P Takes; Primož Strojan; Avi Khafif; Carl E Silver; Alessandra Rinaldo; Jesus E Medina
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-19       Impact factor: 2.503

3.  Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in squamous cell carcinoma of the tongue: markers of nerve invasion?

Authors:  S Doumas; J C Paterson; P M Norris; J V Tighe; L Newman; B S Bisase; A E Kolokotronis; A W Barrett
Journal:  Oral Maxillofac Surg       Date:  2014-07-11

Review 4.  Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinoma.

Authors:  H Hakan Coskun; Jesus E Medina; K Thomas Robbins; Carl E Silver; Primož Strojan; Afshin Teymoortash; Phillip K Pellitteri; Juan P Rodrigo; Sandro J Stoeckli; Ashok R Shaha; Carlos Suárez; Dana M Hartl; Remco de Bree; Robert P Takes; Marc Hamoir; Karen T Pitman; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2014-06-30       Impact factor: 3.147

5.  Postoperative radiotherapy to the neck for pN1 status HNSCC patients after neck dissection.

Authors:  Jia Wang; Xuan Su; Xing Zhang; Wenkuan Chen; Jibin Li; Zhongyuan Yang; Xiyuan Li; Jingtao Chen; Ying Zhang; Shuwei Chen; Ming Song
Journal:  Sci Rep       Date:  2022-08-11       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.